From ocular oncology to tackling neglected diseases, our 2020 Power Listers are making their mark on ophthalmology – and beyond.
VISION 2020: The Right to Sight – what’s next in the global challenge to reduce vision impairment and blindness?
Leading epidemiologists give an overview of the status of vision loss in the seven super-regions of the world
UCL study finds link between fine particulate matter air pollution and increased risk of AMD
The goal of ending global blindness may not have been reached yet, but technologically advanced and affordable diagnostics will help get us there
Keeping patients safe while not compromising their sight in a pandemic has been a constant balancing act
by Santen Pharmaceuticals
GlaucomaFest: the first of its kind in medical education, providing a brand new, immersive virtual experience for ophthalmologists in Europe
The German Society for Tissue Transplantation (DGFG) released its 2020 data, with high levels of donations maintained despite the pandemic
What do the Glaucoma Research Foundation survey results tell us about patients’ pandemic experiences?
Mary Elizabeth Hartnett
The goal of VISION 2020 was to reduce avoidable sight loss, but there is still work to be done to redress gender disparities
A failure to meet preventable blindness targets speaks to the need for change
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.